Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 27
CEO Dr. Thomas R. Cannell
Address 245 First Street Suite 1800, Cambridge, MA 02142
Phone 1.617.444.8550
Website www.sesenbio.com

Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Sesen Bio, Inc. 14.12% -15.32%
Generation Bio Co. -28.99% -64.39%
ViewRay, Inc. -12.14% 33.85%
Nuvalent, Inc. -37.60% n/a
BellRing Brands, Inc. -34.65% 5.49%

Statement Summary

as of 4:00 ET PM 11/29/2021
Total Assets (MRQ) 235.7 M
Total Liabilities (MRQ) 74.7 M
Shareholders’ Equity (MRQ) 161.0 M
Total Revenue (Annual) n/a
Net Income (Annual) 71.6 M

Earnings And Estimates

as of 4:00 ET PM 11/29/2021

Current Qtr EPS Estimate -0.07
Current FY EPS Estimate -0.07
Long Term EPS Growth Estimate 30.00
Next Expected Earnings Date 3/24/2022

SESN vs S&P 500

as of 11/29/2021
Relative To
S&P 500
SESN
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 11/29/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 -0.07 0.36 -614.29%
06/2021 -0.06 -0.15 +136.84%
03/2021 -0.08 -0.35 +356.52%
12/2020 -0.11 -0.11 +3.12%
09/2020 -0.08 -0.19 +139.17%
06/2020 -0.09 -0.24 +157.14%
03/2020 -0.09 0.31 -457.69%
12/2019 -0.08 -0.32 +284.00%

Financial Strength

as of 4:00 ET PM 11/29/2021
Pre-Tax Margin 0.00
Net Margin 0.00
Operating Margin 0.00
Return On Equity -33.70
Return On Assets -14.12
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) 62.55

Ratios

as of 4:00 PM ET 11/29/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 1.30
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 0.81
Quick Ratio (MRQ) 15.92
Current Ratio (MRQ) 15.92
Total Debt/Equity (MRQ) 0.00

Short Interest

as of 4:00 PM ET 11/30/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 11/29/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $-0.07 $-0.05
# of Estimates 3 1
High Estimate $-0.05 $-0.05
Low Estimate $-0.10 $-0.05
Year Ago EPS $-0.11 $-0.35
Year Over Year Growth Estimate -35.73% -85.86%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-0.07 $-0.32
# of Estimates 3 3
High Estimate $0.02 $-0.19
Low Estimate $-0.12 $-0.50
Year Ago EPS $-0.19 $-0.07
Year Over Year Growth Estimate -63.16% 361.90%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.07 $-0.05 $-0.07 $-0.32
# of Estimates 3 1 3 3
High Estimate $-0.05 $-0.05 $0.02 $-0.19
Low Estimate $-0.10 $-0.05 $-0.12 $-0.50
Year Ago EPS $-0.11 $-0.35 $-0.19 $-0.07
Year Over Year Growth Estimate -35.73% -85.86% -63.16% 361.90%

Insider Information Summary

as of 10/31/2021
% Insiders - 0.08%
% Remaining Total Shares - 99.92%
Current 1 Month
Net Insider Transaction 115.00 K 0.00
Shares Bought 115.00 K 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Salesforce Lead

Salesforce Stock Slumps As Outlook Mutes Q3 Earnings Beat, Co-CEO Appointment

Salesforce forecast softer-than-expected fourth quarter profits late Tuesday, and named rising star Bret Taylor as co-CEO of the cloud and business software group alongside founder Marc Benioff.

Asia-Pacific Firms Can Become ESG Global Citizens, Deutsche Bank Regional ESG Head Says

Voltus Reportedly Going Public In SPAC Deal With $1.3 Billion Valuation

Voltus, an ESG startup that helps manage small, decentralized electricity systems, is going public in a SPAC deal that values the company at about $1.3 billion.

Omicron COVID-19 Lead

McMillan: Trader’s Lament—Omicron Casts a Giant Shadow

Avoiding overreacting is key for traders and governments.

Wall Street at Records as GOP Tax Bill Heads to Senate Vote

Salesforce, Merck, Cathie Wood, Twitter; Stocks Rebound - 5 Things You Must Know

Stocks rebound on growth optimism, but Omicron threat lingers; U.S. tightens travel restrictions to tame variant spread; Salesforce slumps on fourth quarter outlook, C-suite changes; Merck gets narrow nod for Covid pill treatment and Cathie Wood adds more Twitter shares to ARK funds following the departure of CEO Jack Dorsey.

Amazon Lead

Cyber Monday Spending Falls From Year Earlier

Shoppers spent $10.7 billion on Cyber Monday down 1.4% year over year, according to data from Adobe.

Salesforce Lead

Salesforce Offers Weak Fourth-Quarter Outlook

The cloud software company expects sales between $7.22 billion and $7.23 billion next quarter.

Zendesk IPO Ignores Selling, Pops 38% on First Day of Trading

Activist Shareholder Leans on Zendesk to Abandon SurveyMonkey Deal

It said it plans to vote its shares against the issuance of Zendesk stock that would be needed to pay for the deal and could seek to replace board members.

Federal Reserve Lead

Cramer's Mad Money Recap 11/30: Amazon, Microsoft, Tesla

Jim Cramer says Fed's bond-buying statement compounded investor worries over Omicron.

Cathie Wood Lead

Ark Investment Management Buys $25M in Robinhood Shares

Robinhood said it had a data breach on Nov. 3 that exposed the data of 7 million or more of its customers.